ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to boost leukemia transplant success
Disease control Not yet recruitingThis study tests a new combination of three chemotherapy drugs (clofarabine, busulfan, and melphalan) given before a stem cell transplant for adults with acute myeloid leukemia (AML) who are in first remission. The goal is to see if this stronger conditioning regimen helps more p…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New blood tests could sharpen CMV watch in transplant patients
Knowledge-focused Not yet recruitingThis study looks at 290 adults who have had a stem cell transplant and are taking letermovir to prevent CMV infection. Researchers want to see if measuring two new viral markers (CMV-RNA and TTV-DNA) in the blood can better predict when CMV becomes active compared to the standard…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC